Study title |
A Study of Benralizumab in Patients With Eosinophilic Esophagitis (MESSINA) |
Disease or condition |
Eosinophilic Esophagitis |
Study type |
Interventional (Clinical Trial) |
Intervention/treatment |
Benralizumab or placebo |
Phase |
3 |
Study site |
University of North Carolina at Chapel Hill |
Study location |
Chapel Hill |
Principal investigator |
Evan Dellon, MD, MPH cedas@med.unc.edu |
Study coordinator |
Kacie Walker, Kacie_Walker@med.unc.edu |
Phone contact |
919-966-0139 |
Clinicaltrials.gov link |
https://clinicaltrials.gov/ct2/show/NCT04543409 |